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Abstract
Background In recent years, conventional colorectal re-
section and its aftercare have increasingly become replaced
by laparoscopic surgery and enhanced recovery after sur-
gery (ERAS) pathways, respectively.
Objective To ascertain whether combining laparoscopy
and ERAS have additional value within colorectal surgery.
Methods A systematic review with meta-analysis was
performed with two primary research questions; does la-
paroscopy offer an advantage when all patients receive
ERAS perioperative care and does ERAS offer advantages
in a laparoscopically operated patient population. All ran-
domised and controlled clinical trials were identified using
MEDLINE, EMBASE and Cochrane databases.
Results Primary search resulted in 319 hits. After inclu-
sion criteria were applied, three RCTs and six CCTs were
included in the meta-analysis. For laparoscopically oper-
ated patients with/without ERAS, no differences in mor-
bidity were found and postoperative hospital stay favoured
ERAS (MD -2.34 [-3.77, -0.91], Z = 3.20, p = 0.001).
When comparing laparoscopy and open surgery within
ERAS, major morbidity was significantly reduced in the
laparoscopic group (OR 0.42 [0.26, 0.66], Z = 3.73,
p = 0.006). Other outcome parameters showed no differ-
ences. Quality of included studies was considered moderate
to poor overall with small sample sizes.
Conclusion When laparoscopy and ERAS are combined,
major morbidity and hospital stay are reduced. The re-
duction in morbidity seems to be due to laparoscopy rather
than ERAS, so laparoscopy by itself offers independent
advantages beyond ERAS care. Quality of included studies
was moderate to poor, so conclusions should be regarded
with some reservations.
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Bowel resections are one of the most commonly performed
surgical procedures today. Colorectal carcinoma is the
second most common cancer worldwide, and other benign
conditions also often require intestinal surgery.
In recent years, the common procedure and conventional
aftercare have become more and more replaced by two new
interventions in the care for bowel surgery. First described
in 1991, laparoscopic (assisted) surgery has been intro-
duced [1]. Scientific evidence supporting laparoscopic
surgery has been accumulating ever since. Large ran-
domised trials and subsequent meta-analyses showed a
reduction in hospital stay and reduced morbidity after la-
paroscopic colorectal oncological resections [2, 3]. Fur-
thermore, oncological radicality was not compromised
using the laparoscopic approach [4]. However, the quality
of trials included could have biased results [3].
The second treatment modality that has gained popu-
larity in recent years is the ‘‘enhanced recovery after sur-
gery’’ pathway (ERAS). This multimodal treatment
modality was first introduced by Kehlet et al. [5] in the mid
1990s and was later developed further by the ERAS
working group [6]. ERAS is based on facilitating early
recovery after major surgery by diminishing the surgical
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trauma and the inherent body’s response, thereby preserv-
ing bodily composition and organ function. It incorporates
17 different items, ranging from pre-operative counselling
and feeding, peri-operative measures to postoperative
mobilisation and early feeding. Most of the items used are
chosen on the basis of high-grade evidence of clinical ef-
ficacy [6]. A recent Cochrane review concludes that ERAS
in colorectal surgery is safe and reduces hospital stay, but
quality of literature is moderate and major complications
are not reduced [7].
Both methods are widely used today, especially in col-
orectal surgery. However, an additional effect of la-
paroscopy within ERAS pathways or vice versa has not
been investigated as well. To date, no meta-analysis has
been published on this subject.
The research question this paper attempts to investigate
is whether laparoscopy and ERAS have additional, i.e.,
synergistic effects in colorectal surgery. To answer this
research question, a systematic search of available evi-
dence regarding laparoscopy within ERAS was obtained.
This resulted in two separate study groups: first studies
looking at laparoscopically operated patients that receive
either ERAS or conventional aftercare; second, studies
looking at laparoscopic versus open operative techniques
while all patients are treated using ERAS. The systematic
review and subsequent meta-analysis were performed ac-
cording to Cochrane guidelines [8] and the manuscript by
Mahid et al. [9].
Materials and methods
The following two research questions were devised before
attending to a systematic review;
1. Does ERAS offer an advantage in colorectal surgery
when all patients are operated on laparoscopically?
2. Does laparoscopy offer an advantage in colorectal
surgery when all patients receive ERAS treatment
protocols?
Relevant studies were identified by performing a sys-
tematic search of MEDLINE, PubMed, EMBASE and
Cochrane databases. No date or language restrictions were
applied. A search string was devised for MEDLINE
databases;
(((((((‘‘Colon’’[Mesh])) OR (‘‘Colonic Diseases’’[Mesh])))
OR (((‘‘Intestines’’[Mesh])) OR (‘‘Intestinal Diseases’’
[Mesh]))) OR ((((intestine OR intestines OR intestinal)) OR
(bowel OR bowels)) OR (colon OR colonic OR colorectal))))
AND (((((((laparoscopic surgery)) OR (laparoscopy))) OR
(‘‘Laparoscopy’’[Mesh]))) AND (((enhanced[tiab] AND
recovery[tiab] AND surgery[tiab])) OR (‘‘fast track’’))).
And this string was changed appropriately for other
databases. No restrictions on date or language of publica-
tion were applied. The data search was updated in March
2014.
Inclusion of studies
All prospective trials that included colorectal surgical pa-
tients and either compared laparoscopic patients that did or
did not receive ERAS or compared patients receiving all
ERAS care with or without laparoscopic intervention were
eligible for inclusion.
The search was independently performed by two authors
(WRS/JvS). Disputes were resolved by discussion, and if
necessary, the judgment of the third reviewer (CvL) was
considered final. Included studies were also hand-searched
for additional relevant references, as were reference lists
from identified review papers. The search process is de-
picted in Fig. 1. Authors from identified conference pro-
ceedings were contacted for full data. Also, studies in
Fig. 1 Search strategy
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progress were identified using the Cochrane CENTRAL
database. One was identified, and authors were contacted
for data. No data were provided.
Exclusion criteria
Trials had to be published in a peer-reviewed indexed
journal. Dual publications or late follow-up from earlier
trials was excluded from meta-analysis. Only randomised
or controlled clinical trials were eligible for meta-analysis.
According to the ERAS working groups’ recommenda-
tions, an ERAS programme should incorporate 17 items
[6]. The difference in the number of intervention used
between the conventional and ERAS groups has to be large
enough in order to judge the effect of the intervention
named ERAS. In line with the recent Cochrane review [7],
we therefore regarded ERAS protocols implementing seven
or more ERAS items and conventional protocols imple-
menting no more than two items to be adequate for
comparison.
Other studies
The systematic search for literature also resulted in several
studies that could not be included in the meta-analysis [10–
17].Although these studies have an inherent increased risk of
bias and did not fulfil inclusion criteria, these studies were
read and outcome measures were reported on descriptively.
Quality assessment and data extraction
All included studies were assessed for quality by using
GRADE methodology [18] and analysed by using the
GRADE profiler tool, as provided by the Cochrane col-
laboration. (GRADE profiler, v3.2.2,  Grade working
group, 2004–2007). Generation of the allocation sequence,
allocation concealment, blinding and follow-up were
analysed.
Data extraction was independently performed by using
specially designed data extraction sheets. Primary end-
points analysed were complications, both major and minor,
readmissions and length of hospital stay. Secondary end-
points included quality of life data, oncological outcome,
pain and pain medication and gastrointestinal function.
For each study, patient characteristics, study character-
istics, data needed for the methodological quality assess-
ment of the study and the primary and secondary outcomes
were extracted according to availability. Data regarding
patient characteristics included number of patients in each
group, age, gender, BMI and diagnoses of included pa-
tients. Data regarding study characteristics included study
design, sample size information, inclusion and exclusion
criteria of the study, follow-up period, loss to follow-up,
surgical experience and information regarding surgical
techniques. For each study, data regarding the periop-
erative interventions in both the ERAS group and con-
ventional group were also extracted.
Data analysis
In order to attempt a meta-analysis, first clinical hetero-
geneity was explored. Meta-analysis was performed using
Review Manager as provided by the Cochrane Collabora-
tion. [Review Manager (RevMan) (Computer program).
Version 5.1. Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2011]. Heterogeneity was
calculated using Higgins Chi-square test and quantified by
measuring I2 [19]. A Chi-square test with a p value of
\0.10 was considered to indicate the presence of hetero-
geneity, while an I2[ 50 % was considered to suggest a
marked inconsistency in effect between studies. In case of
no discrepancy [and no heterogeneity (I2\ 25 %)], the
fixed-effect models is presented. In all other cases, the
random-effects model was used. For dichotomous data
(read-mission rate, morbidity and mortality), OR with
95 % CI was calculated.
Length of hospital stay is divided into primary hospital
stay (PHS) and total length of stay (TLOS = PHS ? days
spent after readmission). Readmissions were defined as
readmissions within 30 days of surgery. All included
studies reported hospital stay as median with interquartile
ranges. Means and SDs were calculated and imputed as
described by Hozo et al. [20]. The lower and upper ends of
the range were calculated by multiplying the difference
between the median and upper and lower ends of the in-
terquartile range by 2 and adding or subtracting the product
from the median.
Complications were divided into major and minor
complications. Mortality was counted as major complica-
tion, but was also assessed separately. Major complications
included abdominal sepsis, anastomotic leakage, need for
reoperation, persistent ileus, intra-abdominal abscesses,
bleeding, burst abdomen (Platzbauch), late incisional her-
nia and adhesions. Minor complications include pneumo-
nia, wound infection, deep vein thrombosis and urinary
tract infection.
Results
Search results
The initial search resulted in 316 hits. After removal of
duplicates, 196 remained. After screening hits on title, 95
hits remained. Abstracts were obtained, which resulted in
30 remaining hits. Five of these were conference
Surg Endosc (2015) 29:3443–3453 3445
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proceedings, and the authors were contacted in order to
obtain full data; none complied. The remaining papers
were obtained, including three review papers. These were
hand-searched and resulted in one additional hit. Full-text
analysis resulted in 14 included papers.
Five of the included studies reported on a randomised
trial [21–25]; however, two studies reported on the LAFA
trial [24, 25], and one study reported on the long-term
outcome of an earlier RCT [23].
Six studies were classified as a controlled clinical trial
(CCT) [26–31]. Polle et al. [32] performed a case–control
study with a retrospective control group and could there-
fore not be included in primary analysis. Scharfenberg
et al. [31] performed a subgroup analysis from data used in
Raue et al. [30] and could therefore not be included in
analysis. Lloyd et al. reported on a prospective trial in-
cluding both open and laparoscopic resections, with or
without an ERAS protocol. However, for inclusion in this
review, only patients within the laparoscopic with or
without ERAS were included, because outcome differences
in the open group were not reported [28]. The remaining
studies were retrospective studies.
Trials included for primary analysis
From the five included RCTs, three could be included for
primary analysis [21, 22, 25]. Vlug et al. used a factorial
designed RCT, reporting on four patient groups; open or
laparoscopic with or without ERAS care. King [22] re-
ported on an RCT comparing laparoscopic and open sur-
gery within an ERAS programme, as did Basse et al. [21].
The RCTs entered 520 patients in total. 98 patients re-
ceived traditional care (TC) in open surgery. 142 patients
received ERAS care and open surgery, while 109 patients
received TC in laparoscopic surgery. Finally, 171 patients
received ERAS care and laparoscopic surgery.
In the CCTs included for analysis, 422 patients were
entered. No patients received TC in open surgery. 105
patients received ERAS care and open surgery, while 80
patients received TC in laparoscopic surgery. Finally, 237
patients received ERAS care and laparoscopic surgery.
Characteristics of included studies
Table 1 shows the general characteristics of included
studies. Baseline characteristics within studies did not
differ. The studies included patients with adenocarcinoma
or adenoma of the colon or rectum [22, 25, 26] or patients
undergoing elective colorectal surgery [21, 28, 30, 33] with
indications such as malignant or benign disease, Crohn’s
disease, ulcerative colitis and diverticular disease.
Number of ERAS items used
The number of ERAS items used in ERAS protocols as
described by authors of included studies was analysed. This
is depicted in Table 1. The included RCTs used a high
number of ERAS items while some of the CCTs only de-
scribed eight. Since this is more than the required seven
ERAS items, these studies were included but could repre-
sent some bias in the studies. However, not all items were
explicitly described, so the actual number of ERAS items
could be higher.
Methodological quality of studies
The quality of included studies was analysed using
GRADE methodology as described earlier. This is
graphically depicted in Figs. 2 and 3. The most recent RCT
by Vlug et al. was well devised and executed. This resulted
in low risk of bias. The older RCTs, however, as well as the
CCTs displayed far more risk of bias. In particular, the
randomisation technique was not well described in the
RCTs and of course absent in the CCTs. But allocation
concealment and blinding were not used well. This is
partially due to the studied intervention. ERAS is largely
dependent on knowledge of both patients and staff con-
cerning the intervention. Therefore, blinding is not possi-
ble. However, the use of open or laparoscopic techniques
can be blinded. Other items were not well described re-
sulting in unclear risk of bias. Overall, the methodological
quality of included studies could be considered moderate to
poor (Fig. 4).
Primary outcome parameters
Morbidity
ERAS versus conventional within laparoscopy When
looking at complications in all, no significant differences
between groups were noted. A subdivision in major com-
plications also showed no difference between groups, nor
did minor complications (Table 2).
Laparoscopy versus open within ERAS Overall, compli-
cations did not differ between groups (Table 2). One study,
however, did not report on overall morbidity, but only re-
ported major morbidity [22]. When looking at major
morbidity, a significant difference did exist, favouring la-
paroscopy (Table 2; Fig. 5) (OR 0.42 [0.26, 0.66],
Z = 3.73, p = 0.006). Minor morbidity was not adequately
reported in one RCT [22] and all of the CCTs [27, 29]. No
difference between groups was noted for minor morbidity.
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123
Mortality
ERAS versus conventional within laparoscopy Studies
reported low mortality, comparable to literature. No sig-
nificant differences between groups were found (Table 2).
Laparoscopy versus open within ERAS Mortality was not
reported in one CCT [27]. Other studies reported relatively
low mortality, comparable to literature. There was no dif-
ference between groups (Table 2).
Readmissions
ERAS versus conventional within laparoscopy For the
ERAS versus conventional groups within laparoscopic
patients, 11 patients were readmitted in the ERAS
population and 11 patients in the conventional group (OR
1.08 [0.46, 2.57]) (Table 2).
Laparoscopy versus open within ERAS Readmissions did
not differ significantly for both groups. For the
Table 1 Age is presented as median, unless mentioned different
Study Design N included Age (years) Sex
(% male)
ASA I or
II (%)
Vlug [42] RCT, factorial 2 9 2 design laparoscopic
± ERAS open ± ERAS
ERAS (open/lap) 93/100 66/66 (mean) 58/53 81/82
TC (open/lap) 98/109 66/68 (mean) 60/62 77/80
Basse [21] RCT, ERAS open/laparoscopic Open 30 75 (57–90) 53 63
Lap. 30 75.5 (58–85) 53 83
King [22] RCT, ERAS open/laparoscopic Open 19 70 (mean) 42 84
Lap. 41 72 (mean) 56 80
Al Chalabi [26] Non randomised CCT, laparoscopic ERAS/TC ERAS 37 53.9 51 57
TC 36 61 67 64
Lloyd [28] Non randomised CCT laparoscopic with ERAS/TC ERAS 55 ns ns ns
TC 15 ns ns ns
MacKay [29] CCT, ERAS open/laparoscopic Open 58 73 (67–82) 43 74
Lap. 22 72 (64–79) 55 77
Junghans [27] CCT, ERAS open/laparoscopic Open 47 67 (31–84) 57 53
Lap. 100 65 (32–76) 48 67
Raue [30] CCT, laparoscopic ERAS/TC ERAS 23 63 (32–76) 35 52
TC 29 65 (38–86) 66 72
CCT controlled clinical trial, RCT randomised controlled trial, TC traditional care, lap. laparoscopic, ns not specified
Fig. 2 ERAS items used in
included studies
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laparoscopic versus open groups within ERAS protocols,
14 patients were readmitted in the laparoscopic groups
versus 22 in the open groups (OR 0.54 [0.27, 1.10])
(Table 2).
Two studies did not adequately report readmissions [27, 28].
Both were CCTs. All readmissions occurred within 30 days.
Length of hospital stay
Length of hospital stay can be divided into postoperative
hospital stay (PHS) and total hospital stay (THS), which is
made up by PHS ? days spent in hospital after readmission.
Most studies only reported onPHSand not described theTHS.
ERAS versus conventional within laparoscopy PHS
favours ERAS when using laparoscopic surgery (Table 2;
Fig. 6) (MD –2.34 [-3.77, -0.91], Z = 3.20, p = 0.001).
THS was only reported by Vlug et al. [25], so no meta-
analysis could be performed. However, Vlug also favoured
ERAS (MD -1.00 [-1.20, -0.80], p\ 0.00001).
Laparoscopy versus open within ERAS When looking at
PHS between open and laparoscopic surgery when using
ERAS, no differences between groups were found (MD
-0.40 [-1.70, 0.91], Z = 0.59, p = 0.55). THS was not
reported well. Basse et al. did report a mean difference
without SD,which showed no significant difference between
groups. Vlug et al. did report THS which favoured the use of
laparoscopy (MD -2.00 [-2.24, 1.76], p\ 0.00001).
Secondary outcome parameters
Quality of life
Three of the included studies analysed quality of life. Vlug
et al. [25] analysed quality of life 2 and 4 weeks
Fig. 3 Risk of bias table according to grade
Fig. 4 Bias items per study according to grade
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postoperatively. No differences existed between groups.
King et al. [22, 23] also found no differences in postop-
erative quality of life between open and laparoscopic
ERAS groups. However, only 58 % of the open patients
felt fully recovered 12 months after surgery versus 88 % of
laparoscopic patients. Mackay et al. [29] also found no
differences in quality of life between open and laparo-
scopic ERAS patients.
Gastrointestinal function
Several studies reported on gastrointestinal function. The
way this was reported did, however, differ significantly
between studies. Van Bree et al. [24] reported on gas-
trointestinal function in the LAFA trial. Gastric emptying
and GI transit were investigated by scintigraphy. Gastric
emptying did not differ, but colonic transit was
Table 2 Summation of forest plots
Laparoscopic ± ERAS groups ERAS Conv ERAS Conv Odds ratio 95 % CI I2 (%) Effect (Z) p
Comparison Total n Events
All complications 215 189 58 54 0.97 [0.62; 1.53] 0 0.11 0.91
Major complications 215 189 24 24 0.95 [0.51; 1.75] 0 0.17 0.86
Minor complications 215 189 49 53 0.84 [0.52; 1.36] 0 0.72 0.47
Mortality 215 189 3 3 1.05 [0.21; 5.30] 0 0.06 0.95
Readmissions 160 174 11 11 1.08 [0.46; 2.57] 0 0.18 0.86
Postoperation hospital stay 215 189 NA NA –2.34a [–3.77; –0.91]a 83 3.20 0.001
ERAS; laparoscopic versus open Laparoscopic Open Laparoscopic Open Odds ratio 95 % CI I2 (%) Effect (Z) p
Comparison Total n Events
All complications 252 228 93 99 0.62 [0.38; 1.01] 30 1.94 0.05
Major complications 271 189 43 57 0.42 [0.26; 0.66] 15 3.73 0.0002
Minor complications 130 123 45 48 1.63 [0.16; 16.31] 86 0.42 0.68
Mortality 193 200 4 9 0.51 [0.16; 1.70] 0 1.09 0.27
Readmissions 193 200 14 22 0.54 [0.27; 1.10] 0 1.71 0.09
Postoperation hospital stay 293 247 NA NA –0.40a [–1.70; 0.91] 73 0.59 0.55
a Mean difference in days, conv conventional
Fig. 5 Forest plot of comparison: laparoscopic versus open surgery within ERAS, outcome: complications, major
Surg Endosc (2015) 29:3443–3453 3449
123
significantly faster in the laparoscopic ERAS group.
Clinically, this did not result in earlier tolerance for food or
passage of stool. Basse [21] and Raue [30] also reported on
gastrointestinal function and found no differences.
Pain and pain medication
Basse et al. [21] reported that laparoscopic patients actually
had a slightly higher pain score on day 0 and 1. This dif-
ference disappeared on day 2. Other studies reported no
differences between groups [29, 30]. In the study by King,
significantly more patients needed additional opioids in the
open group [34]. Not all studies routinely used thoracic
epidural analgesia in their ERAS protocols.
Cost
In hospital, cost did not differ between groups in the LAFA
study, despite the fact that hospital stay was reduced in
both the open ERAS and laparoscopic ERAS groups [25].
King et al. [22] reported that laparoscopic surgery was
more expensive than open surgery, but total cost did not
significantly differ.
Other outcome parameters
No differences were reported for several outcome pa-
rameters, like motor function, pulmonary function and
mental function.
Protocol compliance
Vlug et al. [25] reported on protocol compliance. They
found that out of the analysed 15 elements, the laparo-
scopic ERAS group had a compliance of 11.2 ± 2.2 items.
The open ERAS group complied with 11.1 ± 2.2 items,
while the laparoscopic and open groups with standard care
used 6.0 ± 1.5 and 5.8 ± 1.4 items, respectively. None of
the other studies included reported on protocol compliance.
Discussion
The aim of this review was to investigate whether laparo-
scopic surgery and ERAS have additional, i.e. synergistic
value within colorectal surgery. The systematic search re-
sulted in three RCTs with 520 patients and five CCTs,
including 422 patients. In all, 408 patients received la-
paroscopic ERAS care, 189 patients received laparoscopic
conventional care, and 247 received open ERAS care.
When comparing ERAS and conventional care within
laparoscopic surgery, no differences in complications were
found. In contrast, a Cochrane review showed reduced
complication rates when ERAS was applied in open sur-
gery [7]. Therefore, laparoscopy might offer additional
advantages that cancel out ERAS advantages in compli-
cation rates. To date, large RCTs for laparoscopic versus
open colon surgery showed no differences in complication
rates [35, 36]. However, in these studies, postoperative care
was not standardised and not a part of the studied pa-
rameters. Additionally, a Cochrane review, including 25
RCTs with 3526 participants, did show a significant re-
duction in postoperative complications favouring laparo-
scopic surgery [3].
Other primary outcome parameters also showed no
differences. Readmission numbers did not differ between
groups, but did differ between RCTs, ranging between 20
versus 27 % for laparoscopic and 6 and 8 % for open
surgery groups, respectively. These readmission numbers
are higher than in other trials concerning ERAS care in
Fig. 6 Forest plot of comparison: laparoscopy ± ERAS, outcome: postoperative hospital stay
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open surgery [7]. Postoperative hospital stay when com-
paring ERAS and conventional care in laparoscopic sur-
gery was shorter in the ERAS group (MD -2.34 [-3.77,
-0.91], Z = 3.20, p = 0.001). Therefore, since complica-
tions did not differ, ERAS does improve length of stay in
laparoscopic surgery.
When comparing laparoscopic and open surgery within
ERAS postoperative care, a significant reduction in major
complications favouring laparoscopy was found (OR 0.42
[0.26, 0.66], Z = 3.73, p = 0.006). This is in line with the
earlier statement that laparoscopy offers additional ad-
vantages in complication reduction. Overall morbidity,
readmissions and mortality showed no differences. When
comparing laparoscopic and open surgery with ERAS
postoperative care, no differences for postoperative hos-
pital stay between groups were found (MD -0.45 [-1.53,
0.63], Z = 0.81, p = 0.42).
For hospital stay, however, a lot of heterogeneity was
present, with mean length of stay ranging from 2.3 to
7 days between studies and even differed within groups.
Therefore, these results might be biased by the primary
goal of included studies, as one study had a planned dis-
charge of 2 days postoperative [21]. No studies reported on
the factor ‘‘fulfilling discharge criteria’’, which could be a
more sensitive parameter for speed of recovery, because it
is not influenced by non-medical factors like logistics.
A well-known problem with implementing ERAS pro-
grammes and maintaining them is protocol compliance [32,
37, 38]. Implementing some aspects of ERAS into regular
care and failure to enforce items within the ERAS pro-
gramme could influence results. In this review, only one
study reported on protocol compliance [25]. ERAS com-
pliance was around 11 items, while conventional care also
used around six items. This could have impacted differ-
ences in outcome. Other studies did not report on protocol
compliance, but the number of ERAS items used in the
respective protocols also differed greatly, while all studies
seemed to also incorporate some ERAS items in the con-
ventional group. This could be a large source of bias,
especially in comparison between ERAS and conventional
care.
Secondary outcome parameters showed no differences
between groups. Cost, an often-mentioned factor against
implementing laparoscopic surgery within standard
(=ERAS) colorectal surgical care programmes [39, 40], did
not differ between groups either.
Bias
Methodological quality of studies was moderate to poor
overall, with exception of the LAFA trial [25]; especially
blinding of outcome assessors and clinicians was lacking.
This could have resulted in observer bias, especially for
outcome parameters like hospital stay. Time lag bias could
have been introduced by the fact that trials significantly
diverge in the time frame included trials were undertaken.
Earliest trials are published in 2004, with inclusion in the
early 2000s. The latest trial was published in 2011 and
included patients after 2009.
Not all studies included used high number of ERAS
items in their protocols, and some items (especially tho-
racic epidural analgesia) were used in the conventional
protocol. Although all included studies satisfied the con-
dition of using at least seven items in the ERAS protocol,
this ranged between eight and almost all items. This could
have introduced bias concerning the exact effect of ERAS
as opposed to conventional care.
The combination of these methodological limitations
and bias could have influenced meta-analysis outcome and
also the conclusions for clinical implications.
Other studies
The systematic search also identified several either retro-
spective or non-comparative studies concerning laparo-
scopic surgery with or without ERAS care. Feroci et al.
[11] published a retrospective analysis of a prospective
database including 209 patients receiving laparoscopic
surgery with ERAS care and 141 patients with open ERAS
surgery. Length of stay was reduced in the laparoscopic
group, as were non-surgical complications, time to diet
tolerance, bowel movement and length of analgesia ad-
ministration. This study therefore favours laparoscopic
surgery.
Tsikitis et al. included 197 patients in a retrospective
study comparing laparoscopic surgery with (n = 82) and
without (n = 115) ERAS aftercare. Length of stay and
complications were significantly reduced in favours of
ERAS care. Other studies also favoured laparoscopy with
ERAS care [10, 41]. However, since all of these studies
comprised of retrospective studies a large risk of bias im-
pedes interpretation of these results.
The search also resulted in two ongoing studies. The
first is the TAPAS trial, a prospective cohort trial (n = 225
patients) comparing open surgery and conventional care,
open surgery and ERAS and laparoscopic surgery and
ERAS care for colon carcinoma [42]. Results are expected
shortly. The second trial is the EnROL trial, a phase III,
multicentre, randomised trial of laparoscopic versus open
resection of colon and rectal cancer with blinding of pa-
tients and outcome observers to the treatment allocation
[43]. Both are well designed with adequate power that
could influence results of a future update of this meta-
analysis.
Surg Endosc (2015) 29:3443–3453 3451
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Conclusions
This meta-analysis investigated the possible additional, i.e.
synergistic effects of laparoscopy and ERAS in colorectal
surgery care. Results show a significant reduction in major
morbidity in favour of laparoscopy compared to open
surgery within ERAS care while there was no difference in
complications between conventional care and ERAS in the
laparoscopic group. We therefore conclude that la-
paroscopy has a (major) additional effect within ERAS
care, especially because postoperative hospital stay was
significantly reduced in the laparoscopic group with ERAS
care. However, since the limitations of this meta-analysis
included small sample sizes, high risk of bias due to
lacking methodological quality and lack of protocol im-
plementation control, conclusions should be regarded with
some reservations. Better designed large trials are needed,
and two ongoing trials were identified.
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